🇨🇦 Placebo via ELLIPTA inhaler in Canada

Placebo via ELLIPTA inhaler (Placebo via ELLIPTA inhaler) regulatory status in Canada.

Marketing authorisation

Placebo via ELLIPTA inhaler in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Placebo via ELLIPTA inhaler approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Placebo via ELLIPTA inhaler in Canada?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.